Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Bilen, Mehmet Asim
Subudhi, Sumit K.
Tannir, Nizar M.
Funding for this research was provided by:
National Institutes of Health (CA016672)